Market News & Trends
Hovione & Laxxon Medical Establish Agreement for cGMP Production of 3D Screen-Printed Pharmaceutical Applications
Hovione and Laxxon Medical recently announced a strategic collaboration to advance the use of 3D screen-printing technologies for the pharmaceutical industry. This partnership combines Laxxon's…
Visus Therapeutics Completes Enrollment in Phase 3 Clinical Trial for the Treatment of Presbyopia
Visus Therapeutics Inc. recently announced it has completed patient enrollment and the last visit had been conducted in BRIO-I, a pivotal Phase 3 trial for…
Bio-Rad Launches PTC Tempo 96 & PTC Tempo Deepwell Thermal Cyclers
Bio-Rad Laboratories, Inc. recently announced the launch of its PTC Tempo 96 and PTC Tempo Deepwell Thermal Cyclers, designed to optimize PCR applications, such as…
Woodstock Sterile Solutions Completes Analytical Lab Expansion, Becomes One-Stop Shop CDMO
Woodstock Sterile Solutions has recently completed an expansion of its quality control analytical laboratory at its production facility in Woodstock, IL. The larger laboratory accommodates…
Adare Pharma Solutions Selects Vantage to Lead Major Packaging Facility Upgrade
Adare Pharma Solutions recently announced it has selected Vantage Solutions to lead a major upgrade of their pharmaceutical packaging capabilities. Vantage’s upgrades will allow Adare…
Scorpius BioManufacturing Announces the Appointment of Gary Welch as Interim President
[caption id="attachment_137699" align="alignleft" width="150"] Gary Welch[/caption] Scorpius BioManufacturing recently announced the appointment of Gary Welch as Interim President. With a career spanning more than 30…
Stevanato Group Collaborates With Thermo Fisher Scientific to Bring its Innovative On-Body Delivery System Platform to Market
The companies will offer an integrated device and fill-and-finish solution to streamline the management of the pharmaceutical supply chain….
Halberd Eradicates All Strains of Antibiotic-Resistant E. Coli Provided by the CDC at Youngstown State University
Halberd Corporation recently reported it has successfully eradicated all of the strains of antibiotic-resistant E. coli samples previously provided by the CDC. Using Halberd’s patented…
Pharmaceutics International, Inc. Onboards New Leadership Team to Drive Quality, Operational Improvements & Growth
Pharmaceutics International, Inc. (Pii), a contract development and manufacturing organization (CDMO), recently announced the formation of a new leadership team whose strengths and dedication to…
Vaxxinity Announces First Subjects Dosed in Phase 1 Clinical Trial of Investigational Anti-PCSK9 Vaccine to Treat Hypercholesterolemia
Vaxxinity, Inc. recently announced the first subjects have been dosed in a randomized, double-blind, placebo-controlled Phase 1 clinical trial of VXX-401, an investigational vaccine designed to lower low-density lipoprotein….
Allarity Therapeutics Doses First Patient in Phase 1b Clinical Trial Evaluating Dovitinib & Stenoparib Combination in Advanced Solid Tumors
Allarity Therapeutics, Inc. recently announced it has dosed the first patient in a Phase 1b clinical study evaluating the combination of stenoparib and dovitinib for…
Hovione & Ripple Enter Strategic Partnership to Expand Epidel Platform Into Non-Ophthalmic Space
Hovione and Ripple Therapeutics have entered a strategic partnership to expand the use of Ripple’s Epidel® platform beyond ophthalmic applications….
Synlogic Announces Data Presentations at the Society for Inherited Metabolic Disorders (SIMD) Annual Meeting
Synlogic, Inc. recently announced positive data from the company’s Phase 2 Synpheny-1 study for phenylketonuria (PKU) were presented in a podium presentation yesterday during the…
Enlivex Receives Positive DSMB Recommendation & IMOH Clearance to Continue Phase 1/2 Trial
Enlivex Therapeutics Ltd. recently announced an independent Data and Safety Monitoring Board (DSMB) has completed an interim data review for the first cohort of patients…
Bhami Research Laboratory & Catalent Enter Licensing Agreement for Technology to Deliver High-Concentration Biologics Subcutaneously
Bhami Research Laboratory (BRL) and Catalent recently announced a licensing agreement that will provide Catalent with access to BRL’s formulation technology to help enable the…
Jubilant HollisterStier Announces New President & Upcoming Availability of Expanded Production Capacity for Sterile Injectables
Jubilant HollisterStier (JHS) recently announced the appointment of Chris Preti as President. He brings more than 25 years of broad pharmaceutical industry experience to JHS.…
Gerresheimer Announces Successful FDA Inspection at Peachtree City Site
The Gerresheimer subsidiary in Peachtree City, GA, was named an approved Contract Manufacturer for VERO Biotech’s GENOSYL Delivery System (DS), drug substance intermediate, for the…
Catalent & Grünenthal Announce Successful Collaboration to Facilitate Expedited Clinical Development Timelines
Catalent and Grünenthal recently announced their successful formulation design and clinical-phase manufacturing collaboration for an orally dosed small molecule in Grünenthal's pipeline. Positive preclinical results…
Owlstone Medical Enters Partnership With Bicycle Therapeutics for the Development of Antigen-Targeted EVOC Probes for Early Cancer Detection
Owlstone Medical, the global leader in Breath Biopsy for applications in early disease detection and precision medicine, recently announced it has entered into a Research Agreement with Bicycle Therapeutics plc, a biotechnology company pioneering a new….
Roivant Reports Positive Topline Results From Phase 3 Trial of VTAMA (tapinarof) Cream, 1% Once Daily in Adults & Children as Young as 2
Dermavant Sciences, a Roivant Sciences (Nasdaq: ROIV) company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, recently announced positive results from ADORING 2, one…
